BIRAC inks MoU with Indian Venture and Alternate Capital Association

Biotechnology Industry Research Assistance Council (BIRAC) signed a Memorandum of Understanding (MoU) with the Indian Venture and Alternate Capital Association (IVCA) at the Domestic Institutional Investors (DII) and Exits Forum 2025 to strengthen investor–innovator engagement in India’s biotech ecosystem.

This collaboration aims to create a smoother, more structured pathway for biotech startups as they transition from early-stage government support to market-driven growth.

While many startups receive initial assistance, scaling requires stronger access to capital, investor networks, and market insights. Through this partnership, founders will gain direct, organised avenues to engage with the investment community—whether through policy roundtables, knowledge-sharing platforms, curated pitch sessions, or investor-led showcases.

As India’s biotech sector grows fast and the need for scale-up funding becomes much bigger than before, the timing of this MoU could not be better. It creates space for innovation to move from the lab to commercialisation with greater speed and support. BIRAC will continue working towards an ecosystem where India’s biotech innovators have access to the capital, network, and guidance they need to compete globally.